$NKTX
Nkarta, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
NKTX chart
What traders are saying about $NKTX
Latest postsNkarta, Inc. news
- Patients Deaths and Data Shortfall Spell the End for Cell Therapy Biotech Artiva
MedCity News ·
- Allo and goodbye: Artiva NK cell therapy meets Fate in RA
BioWorld News ·
- Nkarta, Inc. Estimates – NASDAQ:NKTX
TradingView ·
- Nkarta Targets ACR 2026 Data Reveal as Outpatient CAR NK Trials Advance
marketbeat.com ·
- Nkarta to Participate in September Investor Conferences
Yahoo Finance ·
- Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
Yahoo Finance ·
- Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights
Yahoo Finance ·
- Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
Yahoo Finance ·
- Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
Yahoo Finance ·
- Here's Why We're Not Too Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Situation
Yahoo Finance ·
- Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights
Yahoo Finance ·
- NKTX Stock Up on Upbeat Regulatory Update on Lead Autoimmune Program
Yahoo Finance ·
Nkarta, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | – | – |
| Net income | -$104.1M | -$108.8M | -$117.5M | -$113.8M |
| Diluted EPS | $-1.41 | $-1.60 | $-2.40 | $-2.61 |
| Total assets (year end) | $404.2M | $501.2M | $378.9M | $472.9M |
| Cash and equivalents (year end) | $39.6M | $27.9M | $31.0M | $37.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Nkarta, Inc.
- Ticker
- NKTX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1787400
Frequently asked questions
What exchange is Nkarta, Inc. listed on?
Nkarta, Inc. trades on the Nasdaq under the ticker symbol NKTX.
What industry is Nkarta, Inc. in?
Nkarta, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Nkarta, Inc. headquartered?
Nkarta, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Nkarta, Inc.'s fiscal year end?
Nkarta, Inc.'s fiscal year ends on December 31.
How much revenue did Nkarta, Inc. report?
Nkarta, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.